Essity AB

Latest Results (09.02.2026):

Essity AB — Quarter 4 2024: Essity reported Q4 net sales of SEK 37,805m (+3.2% vs Q4 2023) with organic growth of 3.9% (volume +1.7%, price/mix +2.2%). Reported EBITA was SEK 4,585m (-1%), while EBITA excl. IAC rose 2% to SEK 4,969m and EBITA margin excl. IAC was 13.1% (down 0.2 pp). Earnings per share (continuing operations) were SEK 4.13. For full-year 2024 net sales were SEK 145,546m (-1.1%), EBITA increased 17% to SEK 19,475m (EBITA excl. IAC SEK 20,344m, +8%), profit for the period totaled SEK 21,048m (including a ~SEK 9bn gain from the divestment of Vinda), net debt declined sharply to SEK 30,769m, and the Board proposes a dividend of SEK 8.25 per share.

Net sales & organic growth (Q4 & FY)

Q4 2024 net sales SEK 37,805m (+3.2%). Organic growth Q4 +3.9% (volume +1.7%, price/mix +2.2%; excluding restructuring +4.9%). Full-year 2024 net sales SEK 145,546m (-1.1%); organic growth +0.2% (excl. restructuring +1.8%).

Profitability — EBITA and margins

Q4 reported EBITA SEK 4,585m (-1%); EBITA excl. IAC SEK 4,969m (+2%). Q4 EBITA margin excl. IAC 13.1% (down 0.2 pp). Full-year EBITA SEK 19,475m (+17%); EBITA excl. IAC SEK 20,344m (+8%) with margin excl. IAC 14.0% (up 1.2 pp). ROCE improved (full-year ROCE 16.9% and ROCE excl. IAC 17.6%).

Earnings, EPS and one-offs

Q4 profit for the period (total operations) SEK 2,893m (flat YoY). EPS (continuing) Q4 SEK 4.13 (vs 4.04). Full-year profit SEK 21,048m — materially lifted by the capital gain from the Vinda divestment; full-year EPS (total) SEK 29.83 vs SEK 13.60 prior year.

Cash flow & balance sheet

Q4 operating cash flow SEK 3,297m (Q4 2023: 5,914). Full-year operating cash flow SEK 17,242m. Net cash flow from continuing operations for the year SEK 25,635m, driven mainly by the Vinda divestment. Net debt fell to SEK 30,769m at year-end (from SEK 53,703m), aided by the Vinda proceeds (~SEK 19,360m).

Capital allocation — dividend & buybacks

The Board proposes increasing the dividend to SEK 8.25 per share (+6.5%). Essity repurchased 7,398,000 Class B shares in 2024 for SEK 2,224m total; during Q4 it bought back 3,348,000 shares for SEK 1,016m as part of a SEK 3bn buyback program.

Business area performance (Q4 highlights)

Health & Medical: strong volume growth, EBITA excl. IAC +21% (margin 18.3%). Consumer Goods: high volume growth but margin pressured by higher USD-driven raw material costs (EBITA excl. IAC down 13% Q4). Professional Hygiene: premium mix lift, EBITA excl. IAC +19% and margin up (18.3%).

Other notable items

Essity reported a SEK 1.5bn cost‑saving contribution during 2024 and announced the CEO, Magnus Groth, will leave during 2025 (one-year notice). The company continues to raise financial targets and maintain sustainability commitments (SBTi-aligned goals and emissions targets).